Abstract
NHS England is incentivising community pharmacy teams to refer patients considered to be overusing short-acting bronchodilator inhalers to their GP for an asthma review. The referral incentive forms part of the 2022/2023 Pharmacy Quality Scheme (PQS), through which community pharmacies can claim a portion of the £75m available in funding by meeting a set of […]
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
